Document:

Exhibit 10.11

 

QOMOLANGMA ACQUISITION CORP.

FORM OF PRIVATE PLACEMENT UNIT SUBSCRIPTION AGREEMENT

 

This UNIT SUBSCRIPTION AGREEMENT
(this “Agreement”) is made as of this ___ day of ________, 2022, by and between Qomolangma Acquisition Corp.,
a Delaware corporation (the “Company”), having its principal place of business at 1178 Broadway, 3rd
Floor, New York, New York 10001 and Qomolangma Investments LLC, a Delaware limited liability company (the “Purchaser”).

 

WHEREAS, the Company desires to sell on a private placement basis (the
“Offering”) an aggregate of 260,500 units (the “Initial Units”) of the Company, and
up to an additional 24,375 units (“Additional Units” and together with the Initial Units, the “Units”)
of the Company in the event that the underwriters’ 45-day over-allotment option (“Over-Allotment Option”)
in the Offering is exercised in full or part, each Unit comprised of one share of common stock of the Company, par value $0.0001 per share
(the “Common Stock”), one warrant to purchase one share of Common Stock (a “Warrant”),
and one right (the “Right”), for a purchase price of $10.00 per Unit. Each Warrant entitles the holder thereof
to purchase one share of Common Stock (the “Warrant Shares”) to be governed by the Warrant Agreement (defined
herein). Each Right entitles the holder thereof to receive one-tenth (1/10) of one share of Common Stock (the “Right Shares”)
to be governed by the Rights Agreement (defined herein).

 

WHEREAS, the Purchaser desires to purchase the 260,500 Initial Units
and up to 24,375 Additional Units and the Company wishes to accept such subscription.

 

NOW, THEREFORE, in consideration
of the promises and the mutual covenants hereinafter set forth and other good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, the Company and the Purchaser hereby agree as follows:

 

 1. Agreement to Subscribe

 

1.1
Purchase and Issuance of the Units. For the aggregate sum of $2,605,000 (the “Initial Purchase
Price”), upon the terms and subject to the conditions of this Agreement, the Purchaser hereby agrees to purchase from the
Company, and the Company hereby agrees to sell to the Purchaser, on the Closing Date (as defined in Section 1.2) 260,500 Initial Units
at $10.00 per Initial Unit.

 

In addition to the foregoing, the Purchaser hereby agrees to purchase
up to an additional 24,375 Additional Units at $10.00 per Additional Unit for a purchase price of up to $243,750 (the “Additional
Purchase Price” and together with the Initial Purchase Price, the “Purchase Price”). The purchase
and issuance of the Additional Units shall occur only in the event that the Over-Allotment Option is exercised in full or part. The total
number of Additional Units to be purchased hereunder shall be in the same proportion as the amount of the Over-Allotment Option that is
exercised. Each purchase of Additional Units shall occur simultaneously with the consummation of any portion of the Over-Allotment Option.

 

1.2
Closing. The closing of the purchase and sale of the Initial Units shall take place at the offices of Kramer Levin Naftalis
& Frankel LLP, 1177 Avenue of the Americas, New York, New York, 10036 simultaneously with the consummation of the Company’s
initial public offering (“IPO”) of 5,000,000 units (or 5,750,000 units if the underwriter’s over-allotment
is exercised in full) consisting of shares of Common Stock, Warrants and Rights and the purchase and sale of the Additional Units shall
take place upon the consummation of the exercise of all or any portion of the Over-Allotment Option (each a “Closing Date”).

 

     

     

    

 

1.3
Delivery of the Purchase Price. At least one business day prior to the effective date of the Company’s registration
statement relating to the IPO as filed with the Securities and Exchange Commission (SEC File No. 333-____) (“Registration
Statement”), or the date of the exercise of the Over-Allotment Option, if any, the Purchaser agrees to deliver the Initial
Purchase Price or Additional Purchase Price, as the case may be, by certified bank check or wire transfer of immediately available funds
denominated in United States Dollars to American Stock Transfer & Trust Company, LLC, the Company’s transfer agent, which is
hereby irrevocably authorized to deposit such funds on the applicable Closing Date to the trust account which will be established for
the benefit of the Company’s public stockholders, managed pursuant to that certain Investment Management Trust Agreement to be entered
into by and between the Company and American Stock Transfer & Trust Company, LLC and into which substantially all of the proceeds
of the IPO will be deposited (the “Trust Account”). If the IPO is not consummated within 14 days of the date
the Initial Purchase Price is delivered to American Stock Transfer & Trust Company, LLC, the Initial Purchase Price shall be returned
to the Purchaser by certified bank check or wire transfer of immediately available funds denominated in United States Dollars, without
interest or deduction.

 

1.4
Delivery of Unit Certificate. Upon the applicable Closing Date after delivery of the Purchase Price in accordance with Section
1.3, the Purchaser shall become irrevocably entitled to receive a unit certificate representing the Units purchased hereunder.

 

 2. Representations and Warranties of the Purchaser

 

The Purchaser represents and
warrants to the Company that:

 

2.1
No Government Recommendation or Approval. It understands that no United States federal or state agency or similar agency
of any other country has passed upon or made any recommendation or endorsement of the Company, the Offering, the Units, the Warrants,
the Warrant Shares, the Rights, the Right Shares or the shares of Common Stock underlying the Units (excluding the Warrant Shares and
the Right Shares, the “Unit Shares” and, collectively with the Units, the Warrant Shares and the Right Shares,
the “Securities”).

 

2.2
Organization. It is a limited liability company, validly existing and in good standing under the laws of the State of Delaware
and possesses all requisite power and authority necessary to carry out the transactions contemplated by this Agreement.

 

2.3
Private Offering. It is an “accredited investor” as such term is defined in Rule 501(a) of Regulation D under
the Securities Act of 1933, as amended (the “Securities Act”) or it is not a “U.S. Person” as defined
in Rule 902 of Regulation S (“Regulation S”) under the Securities Act. It acknowledges that the sale contemplated
hereby is being made in reliance on a private placement exemption to “Accredited Investors” within the meaning of Section
501(a) of Regulation D under the Securities Act and similar exemptions under state law or a non-U.S. Person under Regulation S.

 

2.4
Authority. This Agreement has been validly authorized, executed and delivered by the Purchaser and is a valid and binding
agreement enforceable in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency,
fraudulent conveyance or similar laws affecting the enforcement of creditors’ rights generally and subject to general principles
of equity (regardless of whether enforcement is sought in a proceeding at law or in equity).

 

2.5
No Conflicts. The execution, delivery and performance of this Agreement and the consummation by the Purchaser of the transactions
contemplated hereby do not violate, conflict with or constitute a default under (i) the Purchaser’s organizational documents, (ii)
any agreement, indenture or instrument to which the Purchaser is a party or (iii) any law, statute, rule or regulation to which the Purchaser
is subject, or any agreement, order, judgment or decree to which the Purchaser is subject.

 

    2

     

    

 

2.6
No Legal Advice from Company. It acknowledges it has had the opportunity to review this Agreement and the transactions contemplated
by this Agreement and the other agreements entered into between the parties hereto with its own legal counsel and investment and tax advisors.
Except for any statements or representations of the Company made in this Agreement and the other agreements entered into between the parties
hereto, it is relying solely on such counsel and advisors and not on any statements or representations of the Company or any of its representatives
or agents for legal, tax or investment advice with respect to this investment, the transactions contemplated by this Agreement or the
securities laws of any jurisdiction. Purchaser understands and acknowledges that the law firm of Kramer Levin Naftalis & Frankel LLP
is not acting as counsel or providing legal advice to Purchaser.

 

2.7
Access to Information; Independent Investigation. Prior to the execution of this Agreement, it has had the opportunity to
ask questions of and receive answers from representatives of the Company concerning an investment in the Company, as well as the finances,
operations, business and prospects of the Company, and the opportunity to obtain additional information to verify the accuracy of all
information so obtained. In determining whether to make this investment, it has relied solely on its own knowledge and understanding of
the Company and its business based upon its own due diligence investigation and the information furnished pursuant to this paragraph.
It understands that no person has been authorized to give any information or to make any representations which were not furnished pursuant
to this Section 2 and it has not relied on any other representations or information in making its investment decision, whether written
or oral, relating to the Company, its operations and/or its prospects.

 

2.8
Reliance on Representations and Warranties. It understands the Units are being offered and sold to it in reliance on exemptions
from the registration requirements under the Securities Act, and analogous provisions in the laws and regulations of various states, and
that the Company is relying upon the truth and accuracy of the representations, warranties, agreements, acknowledgments and understandings
of the Purchaser set forth in this Agreement in order to determine the applicability of such provisions.

 

2.9
No Advertisements. It is not subscribing for the Units as a result of or subsequent to any advertisement, article, notice
or other communication published in any newspaper, magazine, or similar media or broadcast over television or radio, or presented at any
seminar or meeting.

 

2.10
Legend. It acknowledges and agrees the certificates evidencing the Units, the Securities, the Warrants and the Rights shall
bear a restrictive legend (the “Legend”), in form and substance as set forth in Section 4 hereof, prohibiting
the offer, sale, pledge or transfer of the securities, except (i) pursuant to an effective registration statement covering these securities
under the Securities Act or (ii) pursuant to any other exemptions from the registration requirements under the Securities Act and such
laws which, in the opinion of counsel for the Company, is available.

 

2.11
Experience, Financial Capability and Suitability. It is (i) sophisticated in financial matters and is able to evaluate the
risks and benefits of the investment in the Securities and (ii) able to bear the economic risk of its investment in the Securities for
an indefinite period of time because the Securities have not been registered under the Securities Act and therefore cannot be sold unless
subsequently registered under the Securities Act or an exemption from such registration is available. It has substantial experience in
evaluating and investing in transactions of securities in companies similar to the Company so that it is capable of evaluating the merits
and risks of its investment in the Company and has the capacity to protect its own interests. It has substantial experience in evaluating
and investing in transactions of securities in companies similar to the Company so that it is capable of evaluating the merits and risks
of its investment in the Company and has the capacity to protect its own interests.

 

    3

     

    

 

2.12
Investment Purposes. It is purchasing the Securities solely for investment purposes, for its own account and not for the
account or benefit of any other person, and not with a view towards the distribution or dissemination thereof and it has no present arrangement
to sell the interest in the Securities to or through any person or entity.

 

2.13
Restrictions on Transfer. It acknowledges and understands the Units are being offered in a transaction not involving a public
offering in the United States within the meaning of the Securities Act. The Securities have not been registered under the Securities Act,
and, if in the future, it decides to offer, resell, pledge or otherwise transfer the Securities, such Securities may be offered, resold,
pledged or otherwise transferred only (A) pursuant to an effective registration statement filed under the Securities Act, (B) pursuant
to an exemption from registration under Rule 144 promulgated under the Securities Act (“Rule 144”), if available,
or (C) pursuant to any other available exemption from the registration requirements of the Securities Act, and in each case in accordance
with any applicable securities laws of any state or any other jurisdiction. It agrees that if any transfer of its Securities or any interest
therein is proposed to be made, as a condition precedent to any such transfer, it may be required to deliver to the Company an opinion
of counsel satisfactory to the Company. Absent registration or another available exemption from registration, it agrees it will not resell
the Securities. It further acknowledges that because the Company is a shell company, Rule 144 may not be available to it for the resale
of the Securities until the one year anniversary following consummation of the initial Business Combination (defined below) of the Company,
despite technical compliance with the requirements of Rule 144 and the release or waiver of any contractual transfer restrictions. In
addition to the foregoing, the Purchaser acknowledges and agrees that it will be executing an insider letter and lockup agreement with
the Company and Ladenburg Thalmann & Co Inc. as underwriters’ representative, further restricting the Purchaser’s ability
and rights to transfer any Securities.

 

 3. Representations and Warranties of the Company

 

The Company represents and
warrants to the Purchaser that:

 

3.1
Valid Issuance of Share Capital. The total number of all classes of share capital which the Company has authority to issue
is (i) 16,000,000 shares of Common Stock, and 1,000,000 undesignated shares of preferred stock. As of the date hereof, the Company has
issued 1,437,500 shares of Common Stock (of which up to 187,500 shares of Common Stock are subject to forfeiture as described in the Registration
Statement related to the IPO) and has not issued any shares of preferred stock. All of the issued share capital of the Company has been
duly authorized, validly issued, and are fully paid and non-assessable.

 

3.2
Title to Securities. Upon issuance in accordance with, and payment pursuant to, the terms hereof, the warrant agreement
to be entered into with American Stock Transfer & Trust Company, LLC on or prior to the closing of the IPO (“Warrant Agreement”),
the rights agreement to be entered into with American Stock Transfer & Trust Company, LLC on or prior to the closing of the IPO (the
“Rights Agreement”) and the Amended and Restated Certificate of Incorporation of the Company, as the case may
be, each of the Warrants, Rights and the shares of Common Stock will be duly and validly issued, fully paid and non-assessable. On the
date of issuance of the Units, the Warrant Shares and the Right Shares shall have been reserved for issuance. Upon issuance in accordance
with the terms hereof, the Warrant Agreement and the Amended and Restated Certificate of Incorporation of the Company, the Purchaser will
have or receive good title to the Warrant Shares, free and clear of all liens, claims and encumbrances of any kind, and upon issuance
in accordance with the terms hereof, the Rights Agreement and the Amended and Restated Certificate of Incorporation of the Company, the
Purchaser will have or receive good title to the Right Shares, free and clear of all liens, claims and encumbrances of any kind other
than (i) transfer restrictions hereunder and pursuant to the insider letter to be entered into on or prior to the closing of the IPO (the
“Insider Letter”) and (ii) transfer restrictions under federal and state securities laws.

 

3.3
Organization and Qualification. The Company has been duly incorporated and is validly existing as a Delaware corporation
and has the requisite corporate power to own its properties and assets and to carry on its business as now being conducted.

 

    4

     

    

 

3.4
Authorization; Enforcement. (i) The Company has the requisite corporate power and authority to enter into and perform its
obligations under this Agreement and to issue the Securities in accordance with the terms hereof, (ii) the execution, delivery and performance
of this Agreement by the Company and the consummation by it of the transactions contemplated hereby have been duly authorized by all necessary
corporate action and no further consent or authorization of the Company or its Board of Directors or stockholders is required, and (iii)
this Agreement constitutes, and upon the execution and delivery thereof, the Warrants and Warrant Agreement, and the Rights and Rights
Agreement, will constitute, valid and binding obligations of the Company enforceable against the Company in accordance with their respective
terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, fraudulent conveyance, moratorium, reorganization,
or similar laws relating to, or affecting generally the enforcement of, creditors’ rights and remedies or by equitable principles
of general application and except as enforcement of rights to indemnity and contribution may be limited by federal and state securities
laws or principles of public policy.

 

3.5
No Conflicts. The execution, delivery and performance of this Agreement and the consummation by the Company of the transactions
contemplated hereby do not (i) result in a violation of the Company’s Certificate of Incorporation, (ii) conflict with, or constitute
a default under any agreement, indenture or instrument to which the Company is a party or (iii) conflict with any law statute, rule or
regulation to which the Company is subject or any agreement, order, judgment or decree to which the Company is subject. Other than any
federal, state or foreign securities filings which may be required to be made by the Company subsequent to the Closing, and any registration
statement which may be filed pursuant thereto, the Company is not required under federal, state or local law, rule or regulation to obtain
any consent, authorization or order of, or make any filing or registration with, any court or governmental agency or self-regulatory entity
in order for it to perform any of its obligations under this Agreement or issue the Units, the Warrants, the Rights, or the shares of
Common Stock underlying the Units, Warrants or Rights in accordance with the terms hereof.

 

 4. Legends

 

4.1
Legend. The Company will issue the Units, the Warrants, the Rights and the Unit Shares, and when issued, the Warrant Shares
and the Right Shares, purchased by the Purchaser, in the name of the Purchaser. The Securities will bear the following Legend and appropriate
“stop transfer” instructions:

 

THESE SECURITIES (i) HAVE
NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND THESE SECURITIES
MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT (A) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT FILED UNDER THE
SECURITIES ACT, (B) TO A NON-U.S. PERSON IN AN OFFSHORE TRANSACTION IN ACCORDANCE WITH RULE 903 OR RULE 904 OF REGULATION S UNDER THE
SECURITIES ACT, (C) PURSUANT TO THE RESALE LIMITATIONS SET FORTH IN RULE 905 OF REGULATION S UNDER THE SECURITIES ACT, (D) PURSUANT TO
AN EXEMPTION FROM REGISTRATION PROVIDED BY RULE 144 UNDER THE SECURITIES ACT (IF AVAILABLE) OR (E) PURSUANT TO ANY OTHER EXEMPTION FROM
THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT, IN EACH CASE IN ACCORDANCE WITH ANY APPLICABLE SECURITIES LAWS OF ANY STATE OF THE
UNITED STATES OR ANY OTHER JURISDICTION. HEDGING TRANSACTIONS INVOLVING THESE SECURITIES MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH
THE SECURITIES ACT.

 

“THE SECURITIES REPRESENTED
BY THIS CERTIFICATE ARE SUBJECT TO AN AGREEMENT BETWEEN QOMOLANGMA ACQUISITION CORP. AND QOMOLANGMA INVESTMENTS LLC AND MAY ONLY BE OFFERED,
SOLD, TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED DURING THE TERM OF THE LOCKUP PURSUANT TO THE TERMS SET FORTH THEREIN.”

 

    5

     

    

 

4.2
Purchaser’s Compliance. Nothing in this Section 4 shall affect in any way the Purchaser’s obligations and agreements
to comply with all applicable securities laws upon resale of the Securities.

 

4.3
Company’s Refusal to Register Transfer of the Securities. The Company shall refuse to register any transfer of the
Securities, if in the sole judgment of the Company such purported transfer would not be made (i) pursuant to an effective registration
statement filed under the Securities Act, or (ii) pursuant to an available exemption from the registration requirements of the Securities
Act.

 

4.4
Registration Rights. The Purchaser will be entitled to certain registration rights which will be governed by a registration
rights agreement (“Registration Rights Agreement”) to be entered into with the Company on or prior to the closing
of the IPO.

 

 5. Lockup

 

The Purchaser acknowledges
and agrees that the Units, the Warrants, the Rights, the Unit Shares, the Warrant Shares and the Right Shares shall not be transferable,
saleable or assignable until thirty (30) days after the consummation of an acquisition, share exchange, purchase of all or substantially
all of the assets of, or any other similar business combination with one or more businesses or entities (a “Business Combination”),
except to permitted transferees (as defined in the Insider Letter).

 

 6. Securities Laws Restrictions

 

The Purchaser agrees not to
sell, transfer, pledge, hypothecate or otherwise dispose of all or any part of the Securities unless, prior thereto (a) a registration
statement on the appropriate form under the Securities Act and applicable state securities laws with respect to the Securities proposed
to be transferred shall then be effective or (b) the Company shall have received an opinion from counsel reasonably satisfactory to the
Company, that such registration is not required because such transaction complies with the Securities Act and the rules promulgated by
the Securities and Exchange Commission thereunder and with all applicable state securities laws.

 

 7. Waiver of Distributions from Trust Account

 

In connection with the Securities
purchased pursuant to this Agreement, the Purchaser hereby waives any and all right, title, interest or claim of any kind in or to any
distributions from the Trust Account.

 

 8. Rescission Right Waiver and Indemnification

 

8.1
Rescission Waiver. The Purchaser understands and acknowledges that an exemption from the registration requirements of the
Securities Act requires there be no general solicitation of purchasers of the Units. In this regard, if the Offering were deemed to be
a general solicitation with respect to the Units, the offer and sale of such Units may not be exempt from registration and, if not, the
Purchaser may have a right to rescind its purchase of the Units. In order to facilitate the completion of the Offering and in order to
protect the Company, its stockholders and the Trust Account from claims that may adversely affect the Company or the interests of its
stockholders, the Purchaser hereby agrees to waive, to the maximum extent permitted by applicable law, any claims, right to sue or rights
in law or arbitration, as the case may be, to seek rescission of its purchase of the Units as a result of the issuance of the Units being
deemed to be in violation of Section 5 of the Securities Act. The Purchaser acknowledges and agrees this waiver is being made in order
to induce the Company to sell the Units to the Purchaser. The Purchaser agrees the foregoing waiver of rescission rights shall apply to
any and all known or unknown actions, causes of action, suits, claims or proceedings (collectively, “Claims”)
and related losses, costs, penalties, fees, liabilities and damages, whether compensatory, consequential or exemplary, and expenses in
connection therewith, including reasonable attorneys’ and expert witness fees and disbursements and all other expenses reasonably
incurred in investigating, preparing or defending against any Claims, whether pending or threatened, in connection with any present or
future actual or asserted right to rescind the purchase of the Units hereunder or relating to the purchase of the Units and the transactions
contemplated hereby.

 

    6

     

    

 

8.2
No Recourse Against Trust Account. The Purchaser agrees not to seek recourse against the Trust Account for any reason whatsoever
in connection with its purchase of the Units or any Claim that may arise now or in the future.

 

8.3
Section 8 Waiver. The Purchaser agrees that to the extent any waiver of rights under this Section 8 is ineffective as a
matter of law, the Purchaser has offered such waiver for the benefit of the Company as an equitable right that shall survive any statutory
disqualification or bar that applies to a legal right. The Purchaser acknowledges the receipt and sufficiency of consideration received
from the Company hereunder in this regard.

 

 9. Terms of the Unit

 

The Units shall be substantially
identical to the units offered in the IPO as set forth in the Underwriting Agreement, except the Units: (i) will be subject to the transfer
restrictions described herein, and (ii) are being purchased pursuant to an exemption from the registration requirements of the Securities
Act and will become freely tradable only after certain conditions are met or the resale of the Units is registered under the Securities
Act.

 

 10. Governing Law; Jurisdiction; Waiver of Jury Trial

 

This Agreement shall be governed
by and construed in accordance with the laws of the State of New York for agreements made and to be wholly performed within such territory.
The parties hereto hereby waive any right to a jury trial in connection with any litigation pursuant to this Agreement and the transactions
contemplated hereby.

 

 11. Assignment; Entire Agreement; Amendment

 

11.1
Assignment. Neither this Agreement nor any rights hereunder may be assigned by any party to any other person other than
by the Purchaser, without the prior consent of the Company, to one or more persons agreeing to be bound by the terms hereof. Upon such
assignment by a Purchaser, the assignee(s) shall become Purchaser hereunder and have the rights and obligations provided for herein to
the extent of such assignment.

 

11.2
Entire Agreement. This Agreement sets forth the entire agreement and understanding between the parties as to the subject
matter hereof and supersedes any and all prior discussions, agreements and understandings of any and every nature.

 

11.3
Amendment. Except as expressly provided in this Agreement, neither this Agreement nor any term hereof may be amended, waived,
discharged or terminated other than by a written instrument signed by the party against whom enforcement of any such amendment, waiver,
discharge or termination is sought.

 

11.4
Binding upon Successors. This Agreement shall be binding upon and inure to the benefit of the parties hereto and to their
respective heirs, legal representatives, successors and permitted assigns.

 

 12. Notices; Indemnity

 

12.1
Notices. All notices, requests, consents and other communications hereunder shall be in writing, shall be addressed to the
receiving party’s address set forth herein or to such other address as a party may designate by notice hereunder, and shall be either
(a) delivered by hand, (b) sent by overnight courier, or (c) sent by certified mail, return receipt requested, postage prepaid. All notices,
requests, consents and other communications hereunder shall be deemed to have been given either (i) if by hand, at the time of the delivery
thereof to the receiving party at the address of such party set forth above, (ii) if sent by overnight courier, on the next business day
following the day such notice is delivered to the courier service, or (iii) if sent by certified mail, on the fifth business day following
the day such mailing is made.

 

    7

     

    

 

12.2
Indemnification. Except as set forth in Section 8, each party shall indemnify the other party against any loss, cost or
damages (including reasonable attorney’s fees and expenses) incurred as a result of such party’s breach of any representation,
warranty, covenant or agreement set forth in this Agreement.

 

 13. Counterparts

 

This Agreement may be executed
in one or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective
when counterparts have been signed by each party and delivered to the other party, it being understood that both parties need not sign
the same counterpart. In the event that any signature is delivered by facsimile transmission or any other form of electronic delivery,
such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with
the same force and effect as if such signature page were an original thereof.

 

 14. Survival; Severability

 

14.1
Survival. The representations, warranties, covenants and agreements of the parties hereto shall survive the Closing until
one (1) year following the consummation of an initial Business Combination.

 

14.2
Severability. In the event that any provision of this Agreement becomes or is declared by a court of competent jurisdiction
to be illegal, unenforceable or void, this Agreement shall continue in full force and effect without said provision; provided that
no such severability shall be effective if it materially changes the economic benefit of this Agreement to any party.

 

 15. Headings

 

The titles and subtitles used
in this Agreement are used for convenience only and are not to be considered in construing or interpreting this Agreement.

 

 16. Construction

 

The parties hereto have participated
jointly in the negotiation and drafting of this Agreement. If an ambiguity or question of intent or interpretation arises, this Agreement
will be construed as if drafted jointly by the parties hereto and no presumption or burden of proof will arise favoring or disfavoring
any party hereto because of the authorship of any provision of this Agreement. The words “include,” “includes,”
and “including” will be deemed to be followed by “without limitation.” Pronouns in masculine, feminine,
and neuter genders will be construed to include any other gender, and words in the singular form will be construed to include the plural
and vice versa, unless the context otherwise requires. The words “this Agreement,” “herein,” “hereof,”
“hereby,” “hereunder,” and words of similar import refer to this Agreement as a whole and not to
any particular subdivision unless expressly so limited. The parties hereto intend that each representation, warranty, and covenant contained
herein will have independent significance. If any party hereto has breached any representation, warranty, or covenant contained herein
in any respect, the fact that there exists another representation, warranty or covenant relating to the same subject matter (regardless
of the relative levels of specificity) which such party hereto has not breached will not detract from or mitigate the fact that such party
hereto is in breach of the first representation, warranty, or covenant.

 

[remainder of page intentionally left blank]

 

    8

     

    

 

This subscription is accepted by the Company as of the date first written
above.

 

	 	QOMOLANGMA ACQUISITION CORP.
	 	 
	 	By:	                          
	 	Name:	 
	 	Title:	 

 

Accepted and agreed this 

____ day of ____________, 2022

 

	QOMOLANGMA INVESTMENTS LLC	 
	 	 
	By:	                                 	 
	Name:	 	 
	Title:	 	 

 

 

[Signature Page for Private Placement Unit Subscription
Agreement]Document

EOS ENERGY ENTERPRISES, INC.
NON-EMPLOYEE DIRECTOR COMPENSATION POLICY
(Effective as of December 8, 2020 (the “Effective Date”), amended as of September 7, 2022)

1.Establishment of the Policy; Amendment.  Each member of the Board of Directors (the “Board”) of Eos Energy Enterprises, Inc. (the “Company”) who is not an employee or executive officer of the Company or its subsidiaries (each such member, a “Non-Employee Director”) will be eligible to receive the compensation described in this Non-Employee Director Compensation Policy (this “Policy”) for his or her Board service.  This Policy may be amended or terminated at any time in the sole discretion of the Compensation Committee of the Board (the “Compensation Committee”).  The terms of this Policy shall supersede all prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any Non-Employee Director and between any subsidiary of the Company and any of its non-employee directors.  While this Policy remains in effect, the cash compensation and equity grants described in this Policy shall be paid or be made, as applicable, automatically in accordance with the terms of the Policy, without the need for any further action by the Board or the Compensation Committee.

2.Annual Cash Compensation; Payment.  Beginning in calendar year 2021 and for each calendar year thereafter, each individual who is a Non-Employee Director will be paid an annual cash retainer of $25,000.  There are no per‐meeting attendance fees for attending Board meetings or meetings of any committee of the Board.  The annual cash retainer payable hereunder will be paid in equal quarterly installments, in arrears, following the end of the calendar quarter in which the service occurred (pro-rated for any partial months of service).

3.Equity Compensation.  

(a)Generally.  Equity Awards will be granted under the Company’s 2020 Incentive Plan, as amended from time to time (the “Plan”).

(b)Initial Equity Awards

(i)Initial Option Grants.  Each individual who either (x) is a Non-Employee Director on the Effective Date or (y) becomes a Non-Employee Director after the Effective Date will, as promptly as practicable following the Effective Date (in the case of clause (x)) or the commencement of such Non-Employee Director’s service as such (in the case of clause (y)), be granted an Option (as a Nonqualified Stock Option under the Plan) to purchase such number of shares (rounded to the nearest whole number) of Common Stock having an Option Value (as defined below) equal to $75,000 as of the grant date of such Option (the “Initial Option Grant”).  The Initial Option Grant shall vest and become exercisable upon the earlier of (A) the one-year anniversary of the grant date of such Initial Option Grant, and (B) immediately prior to the date of the next annual shareholders meeting of the Company following the grant date of such Initial Option Grant, in each case, subject to the Non-Employee Director’s continuous service as a member of the Board through such vesting date; provided, that, the Initial Option Grant will vest in full immediately prior to, and contingent upon, the consummation of a Change in Control.  For purposes of this Policy, “Option Value” shall mean, with respect to any Award of an Option, the grant date fair value of such Option (i.e., Black-Scholes Value) determined in accordance with the reasonable assumptions and methodologies employed by the 

Company for calculating the fair value of an Option under Accounting Standards Codification 718.

(ii)Initial Restricted Stock Unit Grants.  Each individual who either (x) is a Non-Employee Director on the Effective Date or (y) becomes a Non-Employee Director after the Effective Date will, as promptly as practicable following the Effective Date (in the case of clause (x)) or the commencement of such Non-Employee Director’s service as such (in the case of clause (y)), be granted such number of Restricted Stock Units (rounded to the nearest whole number) in an amount equal to (A) $75,000, divided by (B) the closing sales price for the Common Stock of the Company as listed on The Nasdaq Capital Market under the ticker symbol “EOSE” as of the grant date of such Restricted Stock Units (the “Initial RSU Grant”).  The Initial RSU Grant will vest and be settled on the earlier of (I) the one-year anniversary of the grant date of such Initial RSU Grant, and (II) immediately prior to the date of the next annual shareholders meeting of the Company following the grant date of such Initial RSU Grant, in each case, subject to the Non-Employee Director’s continuous service as a member of the Board through such vesting date; provided, that, the Restricted Stock Units will vest in full immediately prior to, and contingent upon, the consummation of a Change in Control.

(c)Continuing Grants.  

(i)Subject to Section 3(d), on the second trading day following each annual meeting of the Company’s stockholders after the Effective Date, each individual who is then a Non-Employee Director shall be granted (x) an Option (as a Nonqualified Stock Option under the Plan) to purchase such number of shares (rounded to the nearest whole number) of Common Stock having an Option Value equal to $75,000 as of the grant date of such Option (a “Continuing Option Grant”) and (y) such number of Restricted Stock Units (rounded to the nearest whole number) in an amount equal to (A) $75,000, divided by (B) the closing sales price for the Common Stock of the Company as listed on The Nasdaq Capital Market under the ticker symbol “EOSE” as of the grant date of such Restricted Stock Units. (a “Continuing RSU Grant” and, together with the Continuing Option Grant, the “Continuing Grants”).

(ii)Subject to Section 3(d), on the second trading day following each annual meeting of the Company’s stockholders beginning with the 2023 annual meeting: (x) a Non-Employee Director who is then serving as chairperson of the Board or as chairperson of the Audit Committee shall be granted an Option (as a Nonqualified Stock Option under the Plan) to purchase such number of shares (rounded to the nearest whole number) of Common Stock having an Option Value equal to $50,000 as of the grant date of such Option; and (y) a Non-Employee Director who is then serving as chairperson of the Compensation Committee or the Nominating Committee of the Board shall be granted an Option (as a Nonqualified Stock Option under the Plan) to purchase such number of shares (rounded to the nearest whole number) of Common Stock having an Option Value equal to $25,000 as of the grant date of such Option ((x) and (y) together referred to as the “Continuing Chairperson Grants”). Notwithstanding the foregoing, each Non-Employee Director shall be eligible to receive no more than one Continuing Chairperson Grant per year and, in the event any Non-Employee Director would, in the absence of this sentence, be eligible to receive a 

Continuing Chairperson Grant under both clause (x) and clause (y) (or for two grants pursuant to one of clause (x) or clause (y)), such Non-Employee Director shall only receive one Continuing Chairperson Grant pursuant to the terms of the clause that provides for the larger Continuing Chairperson Grant.

(iii)Each Continuing Grant and Continuing Chairperson Grant shall vest and become exercisable upon the earlier of (x) the one-year anniversary of the grant date of such Continuing Grant or Continuing Chairperson Grant, and (y) immediately prior to the date of the next annual shareholders meeting of the Company following the grant date of such Continuing Grant or Continuing Chairperson Grant, in each case, subject to the Non-Employee Director’s continuous service as a member of the Board through such vesting date; provided, that, each Continuing Grant or Continuing Chairperson Grant will vest in full immediately prior to, and contingent upon, the consummation of a Change in Control.  

(d)Continuing Grants for Certain New Non-Employee Directors and New Chairpersons.  

(i)If an individual becomes a Non-Employee Director for the first time other than by election or appointment at an annual meeting of the Company’s stockholders, such Non-Employee Director shall be entitled to receive Continuing Grants in connection with the next annual meeting pursuant to Section 3(c) above; provided, however, that the date on which such individual became a Non-Employee Director is not less than four calendar months prior to the date of the next annual meeting of the Company’s stockholders.  If the date on which such individual became a Non-Employee Director is less than four calendar months prior to the date of the next annual meeting of the Company’s stockholders, then such Non-Employee Director shall not be granted any Continuing Grants pursuant to Section 3(c) above in connection with such next annual meeting of the Company’s stockholders.

(ii)If a Non-Employee Director is newly appointed as a chairperson after the second trading day following the applicable annual meeting of the Company’s stockholders, such Non-Employee Director shall be entitled to receive (A) if such Non-Employee Director did not previously receive a Continuing Chairperson Grant for the applicable year, a Continuing Chairperson Grant for such year, prorated to reflect the applicable period of service, or (B) if such Non-Employee Director previously received a Continuing Chairperson Grant for the applicable year, a grant reflecting the incremental value between such individual’s existing Continuing Chairperson Grant and the Continuing Chairperson Grant such individual would be entitled to receive based on their newly held chairperson position (if any), prorated to reflect the applicable period of service. Any grants to be made under this Section 3(d)(ii) shall be made within thirty days of the date such individual commences service in the applicable chairperson position.

4.Expenses.  The Company will reimburse each Non-Employee Director for all reasonable out-of-pocket expenses incurred by such Non-Employee Director for attending meetings of the Board of any committee thereof; provided, that, such Non-Employee Director timely submits to the Company appropriate documentation substantiating such expenses in accordance with the Company’s expense policy, as in effect from time to time.

5.Capitalized Terms.  Capitalized terms used herein but not defined shall have the meaning ascribed to such term in the Plan.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00348-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00348-of-00352.parquet"}]]